Kristina Anatolyevna Akmalova (K A Akmalova, Kristina Akmalova, Kristina A Akmalova, Kristina A Ryzhikova, K A Ryzhikova)

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 16

Top Topics

Atrial Fibrillation

Arterial Hypertension

Oral Anticoagulants

Top Venues

Drug metabolism and personalized therapy

Terapevticheskii arkhiv

Pharmacogenomics and personalized medicine

Molecular biology reports

This page only lists publications with an associated author ORCID identifier.

Publications

Dmitry Alekseevich Sychev, A I Parusov, I D Loranskaya, Natalia P Denisenko, Kristina Anatolyevna Akmalova, Zhannet Alimovna Sozaeva, O L Turkina, Michael Sergeevich Zastrozhin
[CYP2D6 gene polymorphic markers role in determining the optimal treatment tactics for portal hypertension in patients with liver cirrhosis]. Terapevticheskii arkhiv 94 (2) (2022)
Irina I Sinitsina, Alexey V Boyarko, Ilyas I Temirbulatov, Dmitry Alekseevich Sychev, Kristina Anatolyevna Akmalova, Zhannet Alimovna Sozaeva, Elena A Grishina, Karin Badavievich Mirzaev, Anastasiia V Asoskova, Vladimir P Fisenko
CYP2C9 gene polymorphisms influence on antihypertensive effectiveness and hypouricemic effect of losartan among patients with arterial hypertension: an observational study. Drug metabolism and personalized therapy (2022)
Larisa K Moshetova, Maria M Soshina, Ksenia I Turkina, Elena A Grishina, Zhannet Alimovna Sozaeva, Anastasiya A Kachanova, Kristina Anatolyevna Akmalova, Dmitriy V Ivashchenko, Mikhail S Zastrozhin, Vladimir P Fisenko, Dmitry Alekseevich Sychev
Effect of CYP2D6*4 , CYP2D6*10 polymorphisms on the safety of treatment with timolol maleate in patients with glaucoma. Drug metabolism and personalized therapy (2022)
Andranik Alexandrovich Muradian, Dmitry Alekseevich Sychev, Dmitry Alekseevich Blagovestnov, Zhannet Alimovna Sozaeva, Kristina Anatolyevna Akmalova, Michael Sergeevich Zastrozhin, Leyla Nabievna Kerimova, Vadim Teymurazovich Koroshvili, Irina Alexandrovna Epifanova
The effect of CYP2D6 and CYP2C9 gene polymorphisms on the efficacy and safety of the combination of tramadol and ketorolac used for postoperative pain management in patients after video laparoscopic cholecystectomy. Drug metabolism and personalized therapy (2021)
Dmitriy V Ivashchenko, Daria A Yudelevich, Nina I Buromskaya, Pavel V Shimanov, Roman V Deitch, Kristina Anatolyevna Akmalova, Anastasiya A Kachanova, Irina V Dorina, Marina I Nastovich, Elena A Grishina, Lyudmila M Savchenko, Yuriy S Shevchenko, Dmitry Alekseevich Sychev
CYP2D6 phenotype and ABCB1 haplotypes are associated with antipsychotic safety in adolescents experiencing acute psychotic episodes. Drug metabolism and personalized therapy 37 (1) (2021)
Eric Rytkin, Irina Vladimirovna Bure, Pavel O Bochkov, Kristina Anatolyevna Akmalova, Karin Badavievich Mirzaev, Marina S Cherniaeva, Olga Dmitrievna Ostroumova, Valeriy V Smirnov, Elena A Grishina, Anna G Saribekian, Igor N Sychev, Dmitry Alekseevich Sychev
MicroRNAs as novel biomarkers for rivaroxaban therapeutic drug monitoring. Drug metabolism and personalized therapy 37 (1) (2021)
Dmitriy V Ivashchenko, Daria A Yudelevich, Nina I Buromskaya, Pavel V Shimanov, Roman V Deitch, Kristina Anatolyevna Akmalova, Anastasiya A Kachanova, Irina V Dorina, Marina I Nastovich, Elena A Grishina, Lyudmila M Savchenko, Yuriy S Shevchenko, Dmitry Alekseevich Sychev
CYP2D6 phenotype and ABCB1 haplotypes are associated with antipsychotic safety in adolescents experiencing acute psychotic episodes. Drug metabolism and personalized therapy (2021)
Andranik Alexandrovich Muradian, Dmitry Alekseevich Sychev, Dmitry Alekseevich Blagovestnov, Zhannet Alimovna Sozaeva, Kristina Anatolyevna Akmalova, Michael Sergeevich Zastrozhin, Leyla Nabievna Kerimova, Vadim Teymurazovich Koroshvili, Irina Alexandrovna Epifanova
The effect of CYP2D6 and CYP2C9 gene polymorphisms on the efficacy and safety of the combination of tramadol and ketorolac used for postoperative pain management in patients after video laparoscopic cholecystectomy. Drug metabolism and personalized therapy 37 (1) (2021)
Eric Rytkin, Karin Badavievich Mirzaev, Irina Vladimirovna Bure, Kristina Anatolyevna Akmalova, Sherzod Pardaboevich Abdullaev, Anastasiya A Kachanova, Valeriy V Smirnov, Elena A Grishina, Natalia Lyakhova, Elena Aleshkovich, Anna G Saribekian, Denis Andreev, Alexey Shabunin, Dmitry Alekseevich Sychev
MicroRNAs as Novel Biomarkers for P2Y12 - Inhibitors Resistance Prediction. Pharmacogenomics and personalized medicine 14 (2021)
Eric Rytkin, Irina Vladimirovna Bure, Pavel O Bochkov, Kristina Anatolyevna Akmalova, Karin Badavievich Mirzaev, Marina S Cherniaeva, Olga Dmitrievna Ostroumova, Valeriy V Smirnov, Elena A Grishina, Anna G Saribekian, Igor N Sychev, Dmitry Alekseevich Sychev
MicroRNAs as novel biomarkers for rivaroxaban therapeutic drug monitoring. Drug metabolism and personalized therapy (2021)
Karin Badavievich Mirzaev, Denis S Fedorinov, Kristina Anatolyevna Akmalova, Sherzod Pardaboevich Abdullaev, Anastasiya A Kachanova, Zhannet Alimovna Sozaeva, Elena A Grishina, Gregory N Shuev, E Y Kitaeva, V V Shprakh, S S Suleymanov, L Z Bolieva, M S Sozaeva, S M Zhuchkova, N E Gimaldinova, E E Sidukova, I S Burashnikova, A A Shikaleva, Xenia G Zabudskaya, Dmitry Alekseevich Sychev
[Analysis of carrying clinically significant allelic variants of TPMT and DPYD genes associated with the response to drug therapy in cancer practice among 9 ethnic groups of the Russian Federation]. Terapevticheskii arkhiv 92 (8) (2020)
D A Sychev, O A Baturina, K B Mirzaev, Eric Rytkin, Dmitriy V Ivashchenko, Denis Andreev, Kristina Anatolyevna Akmalova, E A Grishina, Pavel O Bochkov, Roman Shevchenko
CYP2C19*17 May Increase the Risk of Death Among Patients with an Acute Coronary Syndrome and Non-Valvular Atrial Fibrillation Who Receive Clopidogrel and Rivaroxaban. Pharmacogenomics and personalized medicine 13 (2020)
Dmitriy V Ivashchenko, Sofi Z Khoang, Bakhu V Makhmudova, Nina I Buromskaya, Pavel V Shimanov, Roman V Deitch, Kristina Anatolyevna Akmalova, Grigoriy N Shuev, Irina V Dorina, Marina I Nastovich, Eugenia N Shagovenko, Elena A Grishina, Lyudmila M Savchenko, Yuriy S Shevchenko, Dmitry Alekseevich Sychev
Pharmacogenetics of antipsychotics in adolescents with acute psychotic episode during first 14 days after admission: effectiveness and safety evaluation. Drug metabolism and personalized therapy 35 (4) (2020)
N A Chernikova, L L Kamynina, A S Ametov, Dmitry Alekseevich Sychev, Elena A Grishina, Kristina Anatolyevna Akmalova
[The pharmacogenetics of hypoglycemia and the glycemic variability at the patients ith type 2 diabetes mellitus]. Terapevticheskii arkhiv 92 (10) (2020)
Karin Badavievich Mirzaev, K I Samsonova, P P Potapov, Denis Andreev, Elena A Grishina, Kristina Anatolyevna Akmalova, Dmitry Alekseevich Sychev
Genotyping and phenotyping CYP3A4\CYP3A5: no association with antiplatelet effect of clopidogrel. Molecular biology reports 46 (4) (2019)
Margarita N Dorofeeva, Evgenia V Shikh, Zhanna M Sizova, Alisa V Tarasenko, Natalia P Denisenko, Valeriy V Smirnov, Kristina Anatolyevna Akmalova, Zhannet A Sozaeva, Elena A Grishina, Dmitriy A Sychev
Antihypertensive Effect Of Amlodipine In Co-Administration With Omeprazole In Patients With Hypertension And Acid-Related Disorders: Cytochrome P450-Associated Aspects. Pharmacogenomics and personalized medicine 12 (2019)